Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors

By Kuppens I.   Witteveen P.   Schot M.   Schuessler V.   Daehling A.   Beijnen J.   Voest E.   Schellens J.  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 227-235

Springer Publishing Company

Access to resources Recommend Favorite

Weekly Paclitaxel in Elderly Patients with Advanced Breast Cancer: A Dose-Finding Study

By Repetto L.  

Drugs in R&D, Vol. 5, Iss. 1, 2004-01 ,pp. : 11-15

Adis International

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors

By Vidal Laura  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 616-628

Springer Publishing Company

Access to resources Recommend Favorite

A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors

By Traynor Anne   Gordon Michael   Alberti Dona   Mendelson David   Munsey Mark   Wilding George   Gammans Richard   Read William  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 509-515

Springer Publishing Company

Access to resources Recommend Favorite

A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma

By Hollebecque A.   Deutsch E.   Massard C.   Gomez-Roca C.   Bahleda R.   Ribrag V.   Bourgier C.   Lazar V.   Lacroix L.   Gazzah A.   Varga A.   Baere T.   Beier F.   Kroesser S.   Trang K.   Zenke F.   Klevesath M.   Soria Jean-Charles  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1530-1538

Springer Publishing Company

Access to resources Recommend Favorite